Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:

  • gov.je

    Update your notification preferences

  • one.gov.je

    Access government services

  • CAESAR

    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Clinical trials regarding the COVID-19 vaccines currently in use (FOI)

Clinical trials regarding the COVID-19 vaccines currently in use (FOI)

Produced by the Freedom of Information office
Authored by Government of Jersey and published on 19 August 2021.
Prepared internally, no external costs.

Request

A

Please provide the current status of all covid-19 vaccines currently in use in Jersey.

B

I would like to know where they are in currently in the clinical trials and are they still only authorised for emergency use?

C

Please also provide the date they are due to finish the trials.

Response

A

Following extensive clinical trials and authorisation for use by the independent medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), three COVID-19 vaccines are currently in use in the vaccination programme across the UK and on Jersey.

These are:

  • COVID-19 Vaccine Pfizer BioNTech given authorisation for temporary supply by the MHRA on 2 December 2020 and then granted Conditional Marketing Authorisation (CMA) on 9 July 2021.

  • COVID-19 Vaccine AstraZeneca given authorisation for temporary supply by the MHRA on 30 December 2020 and then granted Conditional Marketing Authorisation (CMA) on 24 June 2021.

  • COVID-19 Vaccine Moderna given authorisation for temporary supply by the MHRA on 8 January 2021 and then granted Conditional Marketing Authorisation (CMA) on 1 April 2021.

B

All the vaccines that are authorised have completed the normal three stages of clinical trials and have been tested on tens of thousands of people around the world. A Phase 3 COVID-19 vaccine trial typically involves 30,000 to 40,000 patients.

The trial phases were organised to overlap, speeding up the overall time of vaccine production, but without cutting any corners on trialling the vaccine and ensuring it meets strict standards of safety and effectiveness.

As with any new medicine in the UK, these products will be closely monitored to allow quick identification of new safety information. Data on key outcomes such as efficacy and safety have been published in peer-reviewed journals. Data on long term protection and safety will continue to be collected over the coming years.

The three coronavirus vaccines currently approved for use in the UK through temporary authorisations have been through and completed all the normal stages of vaccine testing, including human studies.

C

As per above all three vaccines are currently approved. For more information see the following link:

COVID-19 vaccination programme - GOV.UK (www.gov.uk)

Our sites
Back to top
rating button